Gagnon Advisors’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.1M | Buy |
|
|||||
|
2025
Q1 | $3.31M | Hold |
|
|||||
|
2024
Q4 | $2.51M | Hold |
|
|||||
|
2024
Q3 | $2.01M | Hold |
|
|||||
|
2024
Q2 | $3.82M | Hold |
|
|||||
|
2024
Q1 | $3.9M | Hold |
|
|||||
|
2023
Q4 | $4.5M | Sell |
|
|||||
|
2023
Q3 | $5.53M | Hold |
|
|||||
|
2023
Q2 | $7.23M | Hold |
|
|||||
|
2023
Q1 | $7.36M | Hold |
|
|||||
|
2022
Q4 | $6.96M | Hold |
|
|||||
|
2022
Q3 | $9.59M | Sell |
|
|||||
|
2022
Q2 | $13.7M | Sell |
|
|||||
|
2022
Q1 | $19.2M | Hold |
|
|||||
|
2021
Q4 | $15.1M | Buy |
|
|||||
|
2021
Q3 | $13.4M | Buy |
|
|||||
|
2021
Q2 | $12.9M | Buy |
|
|||||
|
2021
Q1 | $13.6M | Hold |
|
|||||
|
2020
Q4 | $11.6M | Hold |
|
|||||
|
2020
Q3 | $11.7M | Hold |
|
|||||
|
2020
Q2 | $10.2M | Hold |
|
|||||
|
2020
Q1 | $6.5M | Hold |
|
|||||
|
2019
Q4 | $8.78M | Hold |
|
|||||
|
2019
Q3 | $7.38M | Buy |
|
|||||
|
2019
Q2 | $4.67M | Buy |
|